[1] |
ORYAN A, NAMAZI F, SHARIFIYAZDI H, et al. Clinicopathological findings of a natural outbreak of Theileria annulata in cattle:an emerging disease in southern Iran[J]. Parasitol Res, 2013, 112(1):123-127.
|
[2] |
NARLADKAR B W. Projected economic losses due to vector and vector-borne parasitic diseases in livestock of India and its significance in implementing the concept of integrated practices for vector management[J]. Vet World, 2018, 11(2):151-160.
|
[3] |
RIZK M A, EL-SAYED S A E S, NASSIF M, et al. Assay methods for in vitro and in vivo anti-Babesia drug efficacy testing:current progress, outlook, and challenges[J]. Vet Parasitol, 2020, 279: 109013.
|
[4] |
李友英, 蓝 岚, 潘 瑶, 等. 四川省理塘县牦牛感染泰勒虫的分子流行病学调查及虫种鉴定[J]. 畜牧与兽医, 2021, 53(6):61-66.LI Y Y, LAN L, PAN Y, et al. Molecular epidemiological investigation and species identification of Theileria infection in yaks in Litang county of Sichuan province[J]. Animal Husbandry & Veterinary Medicine, 2021, 53(6):61-66. (in Chinese)
|
[5] |
何晓东. 托克逊县部分地区牛环形泰勒虫病的流行病学调查[D]. 乌鲁木齐:新疆农业大学, 2015.HE X D. Epidemiological investigation Theileria annulata for cattle in parts of Toksun country[D]. Urumqi:Xinjiang Agricultural University, 2015. (in Chinese)
|
[6] |
CHAUSSEPIED M, LANGSLEY G. Theileria transformation of bovine leukocytes:a parasite model for the study of lymphoproliferation[J]. Res Immunol, 1996, 147(3):127-138.
|
[7] |
DOBBELAERE D A E, FERNANDEZ P C, HEUSSLER V T. Theileria parva:taking control of host cell proliferation and survival mechanisms: Microreview[J]. Cell Microbiol, 2000, 2(2):91-99.
|
[8] |
LI Z, LIU J L, ZHAO S Y, et al. Theileria annulata subtelomere-encoded variable secreted protein-TA05575 binds to bovine RBMX2[J]. Front Cell Infect Microbiol, 2021, 11:644983.
|
[9] |
DOBBELAERE D, HEUSSLER V. Transformation of leukocytes by Theileria parva and T. annulata[J]. Annu Rev Microbiol, 1999, 53:1-42.
|
[10] |
KINNAIRD J H, WEIR W, DURRANI Z, et al. A bovine lymphosarcoma cell line infected with Theileria annulata exhibits an irreversible reconfiguration of host cell gene expression[J]. PLoS One, 2013, 8(6):e66833.
|
[11] |
HALLER D, MACKIEWICZ M, GERBER S, et al. Cytoplasmic sequestration of p53 promotes survival in leukocytes transformed by Theileria[J]. Oncogene, 2010, 29(21):3079-3086.
|
[12] |
WOODS K, PERRY C, BRVHLMANN F, et al. Theileria’s strategies and effector mechanisms for host cell transformation:from invasion to immortalization[J]. Front Cell Dev Biol, 2021, 9:662805.
|
[13] |
LIZUNDIA R, CHAUSSEPIED M, HUERRE M, et al. c-Jun NH2-terminal kinase/c-Jun signaling promotes survival and metastasis of B lymphocytes transformed by Theileria[J]. Cancer Res, 2006, 66(12):6105-6110.
|
[14] |
ARAVETI P B, SRIVASTAVA A. Curcumin induced oxidative stress causes autophagy and apoptosis in bovine leucocytes transformed by Theileria annulata[J]. Cell Death Discov, 2019, 5(1):100.
|
[15] |
HUBER S, KARAGENC T, RITLER D, et al. Identification and characterisation of a Theileria annulata proline-rich microtubule and SH3 domain-interacting protein (TaMISHIP) that forms a complex with CLASP1, EB1, and CD2AP at the schizont surface[J]. Cell Microbiol, 2018, 20(7):e12838.
|
[16] |
BAUMGARTNER M, CHAUSSEPIED M, MOREAU M F, et al. Constitutive PI3-K activity is essential for proliferation, but not survival, of Theileria parva-transformed B cells[J]. Cell Microbiol, 2000, 2(4):329-339.
|
[17] |
CHAUSSEPIED M, LALLEMAND D, MOREAU M F, et al. Upregulation of Jun and Fos family members and permanent JNK activity lead to constitutive AP-1 activation in Theileria-transformed leukocytes[J]. Mol Biochem Parasitol, 1998, 94(2):215-226.
|
[18] |
ECHEBLI N, MHADHBI M, CHAUSSEPIED M, et al. Engineering attenuated virulence of a Theileria annulata-infected macrophage[J]. PLoS Negl Trop Dis, 2014, 8(11):e3183.
|
[19] |
HAIDAR M, WHITWORTH J, NOÉ G, et al. TGF-β2 induces Grb2 to recruit PI3-K to TGF-RII that activates JNK/AP-1-signaling and augments invasiveness of Theileria-transformed macrophages[J]. Sci Rep, 2015, 5(1):15688.
|
[20] |
YU L, WEI J, LIU P D. Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer[J]. Semin Cancer Biol, 2021, 25:S1044-579X(21)00188-7.
|
[21] |
DOBBELAERE D, FERNANDEZ P, MACHADO J, et al. Interference by the intracellular parasite Theileria parva with T-cell signal transduction pathways induces transformation and protection against apoptosis[J]. Vet Immunol Immunopathol, 1999, 72(1-2):95-100.
|
[22] |
HEUSSLER V T, KÜENZI P, FRAGA F, et al. The Akt/PKB pathway is constitutively activated in Theileria-transformed leucocytes, but does not directly control constitutive NF-κB activation[J]. Cell Microbiol, 2001, 3(8):537-550.
|
[23] |
MAIDARTI M, ANDERSON R A, TELFER E E. Crosstalk between PTEN/PI3K/Akt signalling and DNA damage in the oocyte:implications for primordial follicle activation, oocyte quality and ageing[J]. Cells, 2020, 9(1):200.
|
[24] |
MARTÍNEZ-SÁEZ O, CHIC N, PASCUAL T, et al. Frequency and spectrum of PIK3CA somatic mutations in breast cancer[J]. Breast Cancer Res, 2020, 22(1):45.
|
[25] |
CAI Y, YOUSEF A, GRANDIS J R, et al. NSAID therapy for PIK3CA-altered colorectal, breast, and head and neck cancer[J]. Adv Biol Regul, 2020, 75:100653.
|
[26] |
YOON C, LU J, RYEOM S W, et al. PIK3R3, part of the regulatory domain of PI3K, is upregulated in sarcoma stem-like cells and promotes invasion, migration, and chemotherapy resistance[J]. Cell Death Dis, 2021, 12(8):749.
|
[27] |
WANG G H, YANG X, LI C, et al. PIK3R3 induces epithelial-to-mesenchymal transition and promotes metastasis in colorectal cancer[J]. Mol Cancer Ther, 2014, 13(7):1837-1847.
|
[28] |
LIANG Y J, YANG W X. Kinesins in MAPK cascade:How kinesin motors are involved in the MAPK pathway?[J]. Gene, 2019, 684:1-9.
|
[29] |
DE LATÉ P L, HAIDAR M, ANSARI H, et al. Theileria highjacks JNK2 into a complex with the macroschizont GPI (Glycosyl Phosphatidyl Inositol)-anchored surface protein p104[J]. Cell Microbiol, 2019, 21(3):e12973.
|
[30] |
DUNN C, WILTSHIRE C, MACLAREN A, et al. Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor[J]. Cell Signal, 2002, 14(7):585-593.
|
[31] |
HAN S T, ZHU L Y, ZHU Y R, et al. Targeting ATF4-dependent pro-survival autophagy to synergize glutaminolysis inhibition[J]. Theranostics, 2021, 11(17):8464-8479.
|
[32] |
ISHIZAWA J, KOJIMA K, CHACHAD D, et al. ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies[J]. Sci Signal, 2016, 9(415):ra17.
|
[33] |
BAGHERI-YARMAND R, WILLIAMS M D, GRUBBS E G, et al. ATF4 targets RET for degradation and is a candidate tumor suppressor gene in medullary thyroid cancer[J]. J Clin Endocrinol Metab, 2017, 102(3):933-941.
|
[34] |
REN P, YUE M, XIAO D B, et al. ATF4 and N-Myc coordinate glutamine metabolism in MYCN-amplified neuroblastoma cells through ASCT2 activation[J]. J Pathol, 2015, 235(1):90-100.
|
[35] |
DOBBELAERE D A E, ROTTENBERG S. Theileria-induced leukocyte transformation[J]. Curr Opin Microbiol, 2003, 6(4):377-382.
|